An Advanced Tool for T Cell Analysis Using Microfluidics Organization: GigaGen Inc. PI: David S. Johnson, Ph.D. Better methods for discovery and monitoring of immune system biomarkers could improve treatment of a variety of diseases and conditions, including cancer, autoimmune diseases, allergies, transplant rejection, and infectious diseases. We are building a novel technology that uses microfluidics and DNA sequencing to understand the immune system in unprecedented ways.

Public Health Relevance

Project Title: An Advanced Tool for T Cell Analysis Using Microfluidics Organization: GigaGen Inc. PI: David S. Johnson, Ph.D. Better methods for discovery and monitoring of immune system biomarkers could improve treatment of a variety of diseases and conditions, including cancer, autoimmune diseases, allergies, transplant rejection, and infectious diseases. We are building a novel technology that uses microfluidics and DNA sequencing to understand the immune system in unprecedented ways.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
3R43AI120313-01S1
Application #
9193662
Study Section
Program Officer
Minnicozzi, Michael
Project Start
2016-03-11
Project End
2016-05-31
Budget Start
2016-03-11
Budget End
2016-05-31
Support Year
1
Fiscal Year
2016
Total Cost
$40,000
Indirect Cost
Name
Gigagen, Inc.
Department
Type
DUNS #
963285189
City
South San Francisco
State
CA
Country
United States
Zip Code
94080